Wenya Ding
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Bacterial biofilms and quorum sensing 7
-
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 3
- Co-authors
- Yanhua Li (9 shared papers)He Lian (5 shared papers)Xueying Chen (8 shared papers)Yonghui Zhou (7 shared papers)Jianqing Chen (5 shared papers)Jin Sun (4 shared papers)Changgeng Xu (4 shared papers)Xiaoyu Ai (3 shared papers)
- Journals
- Frontiers in Pharmacology (9 papers)Frontiers in Microbiology (2 papers)BMC Veterinary Research (1 paper)Biomacromolecules (1 paper)RSC Advances (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenya Ding
25 papers receiving 478 citations
Peers
Comparison fields: 5 of 75
- Pharmaceutical Science 95
- Biomaterials 118
- Molecular Medicine 24
- Complementary and alternative medicine 34
- Endocrinology 22
Countries citing papers authored by Wenya Ding
This map shows the geographic impact of Wenya Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenya Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenya Ding more than expected).
Fields of papers citing papers by Wenya Ding
This network shows the impact of papers produced by Wenya Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenya Ding. The network helps show where Wenya Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenya Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 73 | |
| 2 | 2015 | 42 | |
| 3 | 2018 | 35 | |
| 4 | 2018 | 31 | |
| 5 | 2019 | 28 | |
| 6 | 2018 | 28 | |
| 7 | 2017 | 27 | |
| 8 | 2014 | 24 | |
| 9 | 2017 | 22 | |
| 10 | 2016 | 20 | |
| 11 | 2019 | 16 | |
| 12 | 2017 | 16 | |
| 13 | 2018 | 15 | |
| 14 | 2017 | 13 | |
| 15 | 2022 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2023 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2018 | 9 |
About Wenya Ding
Wenya Ding is a scholar working on Molecular Biology, Pharmaceutical Science, Public Health, Environmental and Occupational Health, Biomaterials and Food Science, having authored 26 papers that have together received 480 indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (7 papers), Streptococcal Infections and Treatments (6 papers), Advanced Drug Delivery Systems (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Drug Solubulity and Delivery Systems (3 papers), Antimicrobial Peptides and Activities (3 papers) and Infections and bacterial resistance (3 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Biomaterials (118 citations), Molecular Medicine (24 citations), Complementary and alternative medicine (34 citations) and Endocrinology (22 citations). Wenya Ding has collaborated with scholars based in China and United States. Frequent co-authors include Yanhua Li, He Lian, Xueying Chen, Yonghui Zhou, Jianqing Chen, Jin Sun, Changgeng Xu, Xiaoyu Ai, Longfa Kou and Xiaoxu Xing. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Microbiology, BMC Veterinary Research, Biomacromolecules and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.